| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cholestasis | D002779 | 23 associated lipids |
| Xanthomatosis, Cerebrotendinous | D019294 | 14 associated lipids |
Total
2
7alpha-Hydroxy-4-cholesten-3-one
7alpha-hydroxy-4-cholesten-3-one is a lipid of Sterol Lipids (ST) class. The related lipids are Steroids and Cholestenones.
Cross Reference
Introduction
To understand associated biological information of 7alpha-Hydroxy-4-cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 7alpha-Hydroxy-4-cholesten-3-one?
There are no associated biomedical information in the current reference collection.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7alpha-Hydroxy-4-cholesten-3-one
PubChem Associated disorders and diseases
What pathways are associated with 7alpha-Hydroxy-4-cholesten-3-one
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 7alpha-Hydroxy-4-cholesten-3-one?
There are no associated biomedical information in the current reference collection.
What functions are associated with 7alpha-Hydroxy-4-cholesten-3-one?
There are no associated biomedical information in the current reference collection.
What lipids are associated with 7alpha-Hydroxy-4-cholesten-3-one?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 7alpha-Hydroxy-4-cholesten-3-one?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with 7alpha-Hydroxy-4-cholesten-3-one?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 7alpha-Hydroxy-4-cholesten-3-one
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Donato LJ et al. | Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry. | 2018 | Clin. Biochem. | pmid:29051033 |
| Othman RA et al. | Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe. | 2017 | J. Pediatr. | pmid:28625503 |
| Mast N et al. | Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum. | 2017 | J. Biol. Chem. | pmid:28190002 |
| Wang Y et al. | Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism. | 2017 | Br. J. Nutr. | pmid:29115200 |
| Zweers SJ et al. | Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge. | 2017 | Hepatol Int | pmid:27696157 |
| Mignarri A et al. | Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis. | 2016 | J. Inherit. Metab. Dis. | pmid:26153518 |
| Blahová T et al. | The effect of colesevelam treatment on bile acid and lipid metabolism and glycemic control in healthy men. | 2016 | Physiol Res | pmid:27539104 |
| Zhang L et al. | Impaired Bile Acid Homeostasis in Children with Severe Acute Malnutrition. | 2016 | PLoS ONE | pmid:27163928 |
| Vlachova M et al. | Diurnal variation in cholesterol 7α-hydroxylase activity is determined by the -203A>C polymorphism of the CYP7A1 gene. | 2016 | Croat. Med. J. | pmid:27106353 |
| Graffner H et al. | The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation. | 2016 | Aliment. Pharmacol. Ther. | pmid:26527417 |
| Chen M et al. | The rate-determining steps of aldo-keto reductases (AKRs), a study on human steroid 5β-reductase (AKR1D1). | 2015 | Chem. Biol. Interact. | pmid:25500266 |
| Rudling M et al. | Specific inhibition of bile acid transport alters plasma lipids and GLP-1. | 2015 | BMC Cardiovasc Disord | pmid:26197999 |
| Camilleri M et al. | Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. | 2015 | Aliment. Pharmacol. Ther. | pmid:25594801 |
| Camilleri M et al. | Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. | 2014 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:25012842 |
| Vlaardingerbroek H et al. | New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. | 2014 | J. Lipid Res. | pmid:24478031 |
| Luo J et al. | A nontumorigenic variant of FGF19 treats cholestatic liver diseases. | 2014 | Sci Transl Med | pmid:25080475 |
| Amano Y et al. | Combinational effects of farnesoid X receptor antagonist and statin on plasma lipid levels and low-density lipoprotein clearance in guinea pigs. | 2014 | Life Sci. | pmid:24805868 |
| Bertolotti M et al. | Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. | 2014 | Clin Interv Aging | pmid:24669190 |
| Pattni SS et al. | Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. | 2013 | Aliment. Pharmacol. Ther. | pmid:23981126 |
| Hirsova P et al. | Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2. | 2013 | Toxicology | pmid:23146761 |